Understanding The Role of UCHL1 in Neurotransmission and Inflammation

Target Name: UCHL1

NCBI ID: G7345

UCHL1

Understanding The Role of UCHL1 in Neurotransmission and Inflammation

UCHL1 (HEL-S-53) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the superfamily of G-coupled proteins, which are characterized by the presence of a hydrogen-bonded intrinsic subunit and a more distal variable subunit that contains a catalytic active site.

UCHL1 is involved in a wide range of physiological processes in the body, including cell signaling, neurotransmitter release, and inflammation. It has been implicated in the development and progression of various neurological and cardiovascular disorders, including Alzheimer's disease, Parkinson's disease, and hypertension.

One of the key functions of UCHL1 is its role in neurotransmitter release. UCHL1 has been shown to play a critical role in the release of neurotransmitters, such as dopamine and serotonin, from the axon terminal of neurons. This is done through its interaction with the neurotransmitter transporter, a protein that transports the neurotransmitters across the blood-brain barrier and into the axon terminal of the neuron.

In addition to its role in neurotransmission, UCHL1 is also involved in the regulation of inflammation. It has been shown to play a critical role in the production of pro-inflammatory cytokines, such as TNF-alpha and IL-1, and in the regulation of their signaling. This is done through its interaction with various intracellular signaling pathways, including the TLR (Toll-like receptor) signaling pathway.

UCHL1 is also involved in the regulation of cell signaling, including the signaling pathways that are responsible for cell growth, differentiation, and survival. It has been shown to play a critical role in the regulation of the PI3K (phosphatidylinositol) signaling pathway, which is responsible for the production of IP3 (inositol triphosphate), a key signaling molecule in this pathway.

In conclusion, UCHL1 is a protein that is involved in a wide range of physiological processes in the body. Its role in neurotransmission, inflammation, and cell signaling is highly suggestive that it may be a drug target or biomarker for a variety of neurological and cardiovascular disorders. Further research is needed to fully understand the precise function of UCHL1 and its potential as a therapeutic target.

Protein Name: Ubiquitin C-terminal Hydrolase L1

Functions: Ubiquitin-protein hydrolase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins (Probable). This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin (PubMed:9774100, PubMed:8639624, PubMed:12408865, PubMed:23359680). Also binds to free monoubiquitin and may prevent its degradation in lysosomes (By similarity). The homodimer may have ATP-independent ubiquitin ligase activity (PubMed:12408865)

The "UCHL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UCHL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets